SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under Section
12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File
Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934
Commission File Number: 001-13785
BMJ MEDICAL MANAGEMENT, INC.
(Exact name of registrant as specified in its charter)
4800 North Federal Highway
Suite 101-E
Boca Raton, Florida 33431
(561) 391-1311
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
Common Shares, par value $.001 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which
a duty to file reports under section 13(a)or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6 [ ]
Rule 12h-3(b)(1)(i) [X]
Approximate number of holders of record as of the certification or notice date:
-----------------------------
Common Shares: 261
-----------------------------
Pursuant to the requirements of the Securities Exchange Act of 1934,
BMJ Medical Management, Inc. has caused this certification/notice to be signed
on its behalf by the undersigned duly authorized person.
DATE: June 18, 1999 By: /s/ David H. Fater
--------------------------------
David H. Fater
Executive Vice President
and Chief Financial Officer
